JP2022519639A5 - - Google Patents
Info
- Publication number
- JP2022519639A5 JP2022519639A5 JP2021545744A JP2021545744A JP2022519639A5 JP 2022519639 A5 JP2022519639 A5 JP 2022519639A5 JP 2021545744 A JP2021545744 A JP 2021545744A JP 2021545744 A JP2021545744 A JP 2021545744A JP 2022519639 A5 JP2022519639 A5 JP 2022519639A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- disease
- acceptable salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800827P | 2019-02-04 | 2019-02-04 | |
| US62/800,827 | 2019-02-04 | ||
| PCT/US2020/016318 WO2020163193A1 (en) | 2019-02-04 | 2020-02-03 | Bicyclic ether o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519639A JP2022519639A (ja) | 2022-03-24 |
| JP2022519639A5 true JP2022519639A5 (enExample) | 2023-02-09 |
| JP7504898B2 JP7504898B2 (ja) | 2024-06-24 |
Family
ID=69740800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545744A Active JP7504898B2 (ja) | 2019-02-04 | 2020-02-03 | 二環式エーテルｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グルコピラノシダーゼ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12522595B2 (enExample) |
| EP (1) | EP3921316A1 (enExample) |
| JP (1) | JP7504898B2 (enExample) |
| AR (1) | AR117989A1 (enExample) |
| TW (1) | TW202045501A (enExample) |
| UY (1) | UY38567A (enExample) |
| WO (1) | WO2020163193A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113372344B (zh) * | 2020-12-24 | 2022-11-01 | 上海药坦药物研究开发有限公司 | 一种氯代六元含氮杂环并咪唑类化合物的合成方法 |
| CN112724133B (zh) * | 2021-01-12 | 2022-03-25 | 湖南复瑞生物医药技术有限责任公司 | 6-溴吡唑并[1,5-a]吡啶的制备方法 |
| CN119569746B (zh) * | 2025-02-06 | 2025-05-13 | 纽欧申医药(上海)有限公司 | 含氮杂环化合物、其药物组合物及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| EP2780014A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| US9051269B2 (en) | 2011-11-18 | 2015-06-09 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2013078320A1 (en) | 2011-11-21 | 2013-05-30 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| JP5989805B2 (ja) | 2012-02-10 | 2016-09-07 | コンステレーション・ファーマシューティカルズ・インコーポレイテッドＣｏｎｓｔｅｌｌａｔｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | メチル基変更酵素の調節物質、組成物及びその使用 |
| MA38341B1 (fr) | 2013-02-11 | 2018-11-30 | Constellation Pharmaceuticals Inc | Modulateurs d'enzymes de modification par méthylation, compositions et utilisations associées |
| US9745305B2 (en) | 2013-03-15 | 2017-08-29 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| US9969716B2 (en) | 2013-08-15 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| EP3868752A1 (en) | 2014-08-28 | 2021-08-25 | Asceneuron SA | Glycosidase inhibitors |
| EP3555087A1 (en) * | 2016-12-16 | 2019-10-23 | Janssen Pharmaceutica NV | Monocyclic oga inhibitor compounds |
| TWI654978B (zh) | 2017-01-27 | 2019-04-01 | 美商美國禮來大藥廠 | 5－甲基－1,2,4－二唑－3－基化合物 |
| WO2018154133A1 (en) * | 2017-02-27 | 2018-08-30 | Janssen Pharmaceutica Nv | [1,2,4]-triazolo [1,5-a]-pyrimidinyl derivatives substituted with piperidine, morpholine or piperazine as oga inhibitors |
-
2020
- 2020-02-03 JP JP2021545744A patent/JP7504898B2/ja active Active
- 2020-02-03 TW TW109103217A patent/TW202045501A/zh unknown
- 2020-02-03 AR ARP200100286A patent/AR117989A1/es unknown
- 2020-02-03 WO PCT/US2020/016318 patent/WO2020163193A1/en not_active Ceased
- 2020-02-03 US US17/428,323 patent/US12522595B2/en active Active
- 2020-02-03 EP EP20709009.3A patent/EP3921316A1/en active Pending
- 2020-02-03 UY UY0001038567A patent/UY38567A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519639A5 (enExample) | ||
| JP2021518340A5 (enExample) | ||
| JP2022500472A5 (enExample) | ||
| JP5302221B2 (ja) | ある種の置換スルフィルイミン類の調製方法 | |
| JP2022553230A (ja) | ジアステレオマー酒石酸エステルによるラセミ体の分割により２－シアノエチル（４ｓ）－４－（４－シアノ－２－メトキシフェニル）－５－エトキシ－２，８－ジメチル－１，４－ジヒドロ－１，６－ナフチリジン－３－カルボキシレートを調製する方法 | |
| TWI631119B (zh) | 抗菌雙芳香族衍生物 | |
| AU2016346207B2 (en) | Intermediates to prepare pyridazinone herbicides, and a process to prepare them | |
| GB2210368A (en) | 2-aryl substituted heterocyclic compounds as antiallergic and anti-inflammatory agents | |
| EP3544613B1 (en) | Gsk-3 inhibitors | |
| JP5187862B2 (ja) | キノリン及びその治療的使用 | |
| KR20210049849A (ko) | 글리코시다제 억제제로서 유용한 피페라진 유도체의 숙시네이트 및 푸마레이트 산 부가염 | |
| CA2810478A1 (en) | Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one | |
| US20200247782A1 (en) | Pyrazole derivatives | |
| WO2013049119A1 (en) | Selective nr2b antagonists | |
| JP2006504690A5 (enExample) | ||
| Mali et al. | Facile approach for the synthesis of rivaroxaban using alternate synthon: reaction, crystallization and isolation in single pot to achieve desired yield, quality and crystal form | |
| JP2023501949A5 (enExample) | ||
| JP2022510430A5 (enExample) | ||
| CA2876459A1 (en) | Imidazo[2,1]thiazol-3-one derivatives useful as diagnostic agents for alzheimer's disease | |
| JP2022524077A5 (enExample) | ||
| US8501658B2 (en) | Enantioselective reactions catalyzed by chiral triazolium salts | |
| JP2008536841A (ja) | ３，４−ジヒドロ−ベンゾ［ｅ］［１，３］オキサジン−２−オン | |
| US20090227583A1 (en) | 2-aminoquinolines | |
| CA2565689A1 (en) | Substituted pyrrolidine-2-ones | |
| Pandey et al. | Asymmetric Syntheses of S, S-Dialkyl-Substituted Sulfoximines and Related Heterocycles |